180 related articles for article (PubMed ID: 6747681)
1. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report.
Greenberg HS; Ensminger WD; Seeger JF; Kindt GW; Chandler F; Doan K; Dakhil SR
Cancer Treat Rep; 1981; 65(9-10):803-10. PubMed ID: 7023671
[TBL] [Abstract][Full Text] [Related]
3. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
[TBL] [Abstract][Full Text] [Related]
5. [Internal carotid arterial BCNU perfusion in the treatment of cerebral glioma].
Wu ZL
Zhonghua Wai Ke Za Zhi; 1989 Jul; 27(7):421-3, 446. PubMed ID: 2598744
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET.
Tyler JL; Yamamoto YL; Diksic M; Théron J; Villemure JG; Worthington C; Evans AC; Feindel W
J Nucl Med; 1986 Jun; 27(6):775-80. PubMed ID: 3486962
[TBL] [Abstract][Full Text] [Related]
7. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme.
Bashir R; Hochberg FH; Linggood RM; Hottleman K
J Neurosurg; 1988 Jun; 68(6):917-9. PubMed ID: 2836567
[TBL] [Abstract][Full Text] [Related]
8. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
Safdari H; Mompeon B; Dubois JB; Gros C
Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
[TBL] [Abstract][Full Text] [Related]
9. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
Kapp J; Vance R; Parker JL; Smith RR
Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
[No Abstract] [Full Text] [Related]
10. Ischemic optic neuropathy secondary to intracarotid infusion of BCNU.
Pickrell L; Purvin V
J Clin Neuroophthalmol; 1987 Jun; 7(2):87-92. PubMed ID: 2956289
[TBL] [Abstract][Full Text] [Related]
11. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.
Hochberg FH; Pruitt AA; Beck DO; DeBrun G; Davis K
J Neurosurg; 1985 Dec; 63(6):876-80. PubMed ID: 2997415
[TBL] [Abstract][Full Text] [Related]
12. Reduced systemic drug exposure by combining intra-arterial chemotherapy with hemoperfusion of regional venous drainage.
Oldfield EH; Dedrick RL; Yeager RL; Clark WC; DeVroom HL; Chatterji DC; Doppman JL
J Neurosurg; 1985 Nov; 63(5):726-32. PubMed ID: 4056874
[TBL] [Abstract][Full Text] [Related]
13. Superselective cerebral arterial infusion of BCNU in high-grade glioma: the radiologist's point of view.
Fontaine S; Théron J; Melanson D; Villemure JG; Emrich J; Raymond J; Ethier R
Can Assoc Radiol J; 1988 Sep; 39(3):178-81. PubMed ID: 2971050
[TBL] [Abstract][Full Text] [Related]
14. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
Brem H; Ewend MG; Piantadosi S; Greenhoot J; Burger PC; Sisti M
J Neurooncol; 1995 Nov; 26(2):111-23. PubMed ID: 8787853
[TBL] [Abstract][Full Text] [Related]
15. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
16. Orbital angiographic changes after intracarotid BCNU chemotherapy.
Gebarski SS; Greenberg HS; Gabrielsen TO; Vine AK
AJNR Am J Neuroradiol; 1984; 5(1):55-8. PubMed ID: 6421125
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR
Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
[TBL] [Abstract][Full Text] [Related]
18. Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations.
Théron J; Villemure JG; Worthington C; Tyler JL
Neuroradiology; 1986; 28(2):118-25. PubMed ID: 3703233
[TBL] [Abstract][Full Text] [Related]
19. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas.
Mahaley MS; Whaley RA; Blue M; Bertsch L
J Neurooncol; 1986; 3(4):297-314. PubMed ID: 3958776
[TBL] [Abstract][Full Text] [Related]
20. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.
Miller DF; Bay JW; Lederman RJ; Purvis JD; Rogers LR; Tomsak RL
Ophthalmology; 1985 Mar; 92(3):402-6. PubMed ID: 2986069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
